Journal
AGEING RESEARCH REVIEWS
Volume 47, Issue -, Pages 168-175Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.arr.2018.08.002
Keywords
AMP-activated protein kinase; Myocardial ischemia; Cardiac ageing; Glucose metabolism; Mitochondrial biosynthesis
Categories
Funding
- National Natural Science Foundation of China [81500263, 81370352]
- China Postdoctoral Science Foundation [2016T90973, 2015M572681]
- Natural Science Foundation of Shaanxi Province [52018-JC-YB-1960, 2017ZDJC-07]
Ask authors/readers for more resources
AMP-activated protein kinase (AMPK) is a pivotal regulator of some endogenous defensive molecules in various pathological processes, particularly myocardial ischemia (MI), a high risk of myocardial infarction. Thereby it is of great significance to explore the inherent mechanism between AMPK and myocardial infarction. In this review, we first introduce the structure and role of AMPK in the heart. Next, we introduce the mechanisms of AMPK in the heart; followed by the energy regulation of AMPK in MI. Lastly, the attention will be expanded to some potential directions and further perspectives. The information compiled here will be helpful for further research and drug design in the future before AMPK might be considered as a therapeutic target of MI.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available